Estimated reading time: 2 minutes
In a recent study, Vertex Pharmaceuticals announced promising results from a late-stage clinical trial of their experimental pain medicine, VX-548. The drug demonstrated superiority over a placebo in relieving pain following two different surgeries. Abdominoplasty, also known as a tummy tuck, and bunionectomy, which is surgery on the foot. Additionally, a smaller Phase 3 study indicated the drug's efficacy and safety for acute pain relief across various conditions.
Trial Results
While VX-548 did not outperform an opioid treatment in terms of efficacy, it showed similar pain relief results on the Numeric Pain Rating Scale. This suggests VX-548 could potentially offer an alternative to opioids, mitigating concerns surrounding safety and addiction.
Despite previous attempts to develop pain drugs targeting sodium channels, VX-548's success suggests a more focused approach to NaV1.8 inhibition. Vertex aims to broaden approval for VX-548 to encompass various pain conditions, including diabetic peripheral neuropathy.
A New Drug Classification
If approved by the FDA, VX-548 could represent the first new class of acute pain medicine in over two decades. The drug works by blocking pain in the peripheral nervous system rather than acting on the brain, targeting a specific sodium channel called NaV1.8. This mechanism differs from opioids, addressing the challenges associated with their use.
The issue with opioids is well known. They can cause breathing difficulties and are the leading cause of drug overdoses worldwide. The CDC estimated that 75% of drug overdose deaths in 2021 involved an opioid. Three distinct "waves" have been charted. In 1990s prescription opioids were most common. In 2010 heroin rapidly increased fatalities, and in 2013 synthetics like fentanyl hit the streets.
Overall, VX-548's promising results offer hope for addressing acute pain while potentially reducing reliance on opioids, marking a significant development in pain management.
Over 300,000 members have joined PatientsLikeMe to manage their chronic pain. We have resources, health tracking tools, and community challenges to help with condition management. Creating an account is free! Join today.